Global Hematology Diagnostics Market Research Report 2022

Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets.
Due to the COVID-19 pandemic, the global Hematology Diagnostics market size is estimated to be worth US$ 2121.2 million in 2021 and is forecast to a readjusted size of US$ 2730.1 million by 2028 with a CAGR of 3.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Hematology Diagnostics market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hematology Diagnostics landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detect small cell populations in order to diagnose rare blood conditions, which requires less labor, rapid result, and easy-to-use analyzers. Current technologies include automation of hematology analyzer, electrical impedance, flow cytometry, and fluorescent flow.
This report focuses on Hematology Diagnostics volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hematology Diagnostics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Hematology Diagnostics Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Hematology Instruments
Hematology Consumables
Segment by Application
Diagnostic Laboratories
Hospitals & Clinics
Academic Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott Laboratories
Sysmex Corporation
F. Hoffmann-La Roche
Beckman Coulter